As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Portman Square Capital LLP, NorthCrest Asset Manangement LLC, Wealth Enhancement Advisory Services LLC, JPMorgan Chase & Co., Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Readystate Asset Management LP, Point72 DIFC Ltd, Parallax Volatility Advisers L.P., Maven Securities LTD, HighTower Advisors LLC, Centiva Capital LP, Verition Fund Management LLC, Capstone Investment Advisors LLC, Walleye Trading LLC, Walleye Capital LLC, PEAK6 Investments LLC, BNP Paribas Financial Markets, DRW Securities LLC, Citigroup Inc., Marathon Trading Investment Management LLC, Gladius Capital Management LP, Wolverine Asset Management LLC, SpiderRock Advisors LLC, Genus Capital Management Inc., Wealth Enhancement Advisory Services LLC, and NorthCrest Asset Manangement LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.